WHO ICTRP trial
An observational, real-world clinical study for new drug therapy of newly…
ChiCTR2000029925 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000029925 |
|---|---|
| Public title | An observational, real-world clinical study for new drug therapy of newly diagnosed multiple myeloma in elderly patients in western China |
| Scientific title | An observational, real-world clinical study for new drug therapy of newly diagnosed multiple myeloma in elderly patients in western China |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Multiple myeloma |
| Interventions | Case series:Nil |
| Registration date | Feb 16, 2020 |
| Target size | Case series:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: